{"count": 1, "results": [{"_id": "14631333", "pmid": 14631333, "title": "[Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits?].", "journal": "Diabetes Metab", "authors": ["Blicklé JF"], "date": "2003-11-01T00:00:00Z", "doi": "10.1016/s1262-3636(07)70070-8", "meta_date_publication": "2003 Nov", "meta_volume": "29", "meta_issue": "5", "meta_pages": "547-53", "score": 50046.945, "text_hl": "A relative risk reduction of conversion from @<m>DISEASE_Usher_Syndrome_Type_IG</m> @DISEASE_MESH:C564643 @@@IG@@@ to @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ has been obtained with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Prevention Program, but this effect seems to be directly linked to the antihyperglycaemic effect of the drug. ", "citations": {"NLM": "Blicklé JF. [Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits?]. Diabetes Metab. 2003 Nov;29(5):547-53. PMID: 14631333", "BibTeX": "@article{14631333, title={[Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits?].}, author={Blicklé JF}, journal={Diabetes Metab}, volume={29}, number={5}, pages={547-53}}"}}]}